- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/525 - Isoalloxazines, e.g. riboflavins, vitamin B2
Patent holdings for IPC class A61K 31/525
Total number of patents in this class: 682
10-year publication summary
|
62
|
71
|
60
|
64
|
74
|
52
|
107
|
97
|
87
|
16
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| DSM IP Assets B.V. | 5856 |
48 |
| Société des Produits Nestlé S.A. | 9672 |
29 |
| CXL Ophthalmics, LLC | 18 |
11 |
| Exeltis USA, Inc. | 22 |
9 |
| Nutri Co., Ltd. | 49 |
9 |
| Zensun (Shanghai) Science & Technology, Co., Ltd. | 53 |
9 |
| Avedro, Inc. | 120 |
8 |
| Sooft Italia SpA | 17 |
8 |
| Nulixir Inc. | 37 |
8 |
| Matthias W. Rath | 22 |
7 |
| TIMA Foundation | 14 |
7 |
| Nestec S.A. | 2777 |
6 |
| Ajinomoto Co., Inc. | 2337 |
6 |
| Trioptotec GmbH | 18 |
6 |
| The Board of Trustees of the Leland Stanford Junior University | 6054 |
5 |
| Academisch Ziekenhuis Groningen | 104 |
5 |
| Aprofol AG | 21 |
5 |
| Kaeco Group, Inc. | 10 |
5 |
| N.V. Nutricia | 1022 |
5 |
| Reven Pharmaceuticals, Inc. | 11 |
5 |
| Other owners | 481 |